Table 5. Factors affecting nonrelapse... | American Society of Hematology

Table 5.

Factors affecting nonrelapse mortality in patients without de novo chronic GVHD

	No.	HR	95% CI	P
Response to ECP^*
CR/PR	23	0.3	0.1-0.8	.01
All others	21	—	—	—
Platelets at ECP†
Fewer than 100,000/mm³	19	29	6.2-142	< .001
100,000/mm³ or more	25	—	—	—
LDH
1000 IU/L or lower	30	—	—	—
More than 1000 IU/L	15	3.1	1.4-6.9	.005
No. prior treatments‡
2	25	2.4	0.9-6.1	.06
3	20	—	—	—

	No.	HR	95% CI	P
Response to ECP^*
CR/PR	23	0.3	0.1-0.8	.01
All others	21	—	—	—
Platelets at ECP†
Fewer than 100,000/mm³	19	29	6.2-142	< .001
100,000/mm³ or more	25	—	—	—
LDH
1000 IU/L or lower	30	—	—	—
More than 1000 IU/L	15	3.1	1.4-6.9	.005
No. prior treatments‡
2	25	2.4	0.9-6.1	.06
3	20	—	—	—

— indicates not applicable.

Including tacrolimus or cyclosporine.

100 000/mm³ is equal to 100 × 10⁹/L.

Evaluated since time of response. Two patients who died on the day the response was evaluated are excluded.